117 related articles for article (PubMed ID: 23455799)
1. A case of collision tumor or transdifferentiation between malignant melanoma and leiomyosarcoma.
Ul-Mulk J; Rasmussen H; Breiting L; Siim E
Indian J Pathol Microbiol; 2012; 55(4):538-9. PubMed ID: 23455799
[TBL] [Abstract][Full Text] [Related]
2. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.
Díaz A; Valera A; Carrera C; Hakim S; Aguilera P; García A; Palou J; Puig S; Malvehy J; Alos L
Am J Surg Pathol; 2011 Nov; 35(11):1733-42. PubMed ID: 21997694
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
6. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
Mérot Y; Mihm MC
Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
[TBL] [Abstract][Full Text] [Related]
7. bcl-2 protein expression in melanocytic neoplasms of the skin.
Ramsay JA; From L; Kahn HJ
Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
[TBL] [Abstract][Full Text] [Related]
8. [Pitfalls in the diagnosis of malignant melanoma].
Orosz Z
Magy Onkol; 2003; 47(1):27-39. PubMed ID: 12704452
[TBL] [Abstract][Full Text] [Related]
9. [Pigmented spindle cell nevus and pigmented Spitz nevus--clinical and histopathological study on pigmented Spitz nevus, and its differentiation from early melanoma by fluorescence method and measurement of 5-S-CD level in the lesion].
Takeuchi M; Morishima T
Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1153-65. PubMed ID: 2273578
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
11. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
McCluggage WG; Bissonnette JP; Young RH
Int J Gynecol Pathol; 2006 Oct; 25(4):321-9. PubMed ID: 16990706
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
13. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
[TBL] [Abstract][Full Text] [Related]
14. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
15. Desmoplastic melanoma.
Busam KJ
Clin Lab Med; 2011 Jun; 31(2):321-30. PubMed ID: 21549245
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
Eyden B; Pandit D; Banerjee SS
Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
[TBL] [Abstract][Full Text] [Related]
17. Divergent differentiation in malignant melanomas: a review.
Banerjee SS; Eyden B
Histopathology; 2008 Jan; 52(2):119-29. PubMed ID: 17825057
[TBL] [Abstract][Full Text] [Related]
18. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
19. Superficial malignant peripheral nerve sheath tumor with overlying intradermal melanocytic nevus mimicking spindle cell melanoma.
Jackson CR; Minca EC; Kapil JP; Smith SC; Billings SD
J Cutan Pathol; 2016 Dec; 43(12):1220-1225. PubMed ID: 27687011
[TBL] [Abstract][Full Text] [Related]
20. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
